FULGENT GENETICS, INC. Earnings Per Share (Basic)
FULGENT GENETICS, INC. (FLGT) reported Earnings Per Share (Basic) of -$0.11 per share for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-22.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2019-03-22
- FULGENT GENETICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.05.
- FULGENT GENETICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.80.
- FULGENT GENETICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.76.
- FULGENT GENETICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.21.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.85 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$2.60 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$2.80 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2026-03-31 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$1.78 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$2.40 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2025-12-31 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.97 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2025-09-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.21 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$1.40 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2025-06-30 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2025-03-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-05-01 |
| 2024-12-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-09-30 | -$0.48 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$0.77 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$5.50 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-06-30 | -$0.29 derived: net income ÷ weighted average shares · filed 2025-08-01 | -$0.74 derived: net income ÷ weighted average shares · filed 2025-08-01 | -$5.03 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$5.46 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-03-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-05-02 | -$4.76 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$5.18 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$5.56 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2023-12-31 | -$4.30 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$4.73 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$5.11 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$5.63 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2023-09-30 | -$0.44 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-11-08 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-11-08 | |
| 2023-06-30 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-08-02 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-08-02 | ||
| 2023-03-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-05-03 | |||
| 2022-12-31 | $4.76 derived: net income ÷ weighted average shares · filed 2025-02-28 | |||
| 2021-12-31 | $17.25 derived: net income ÷ weighted average shares · filed 2024-02-28 | |||
| 2018-12-31 | -$0.11 10-K · filed 2019-03-22 | |||
| 2018-09-30 | -$0.03 10-K · filed 2019-03-22 | |||
| 2018-06-30 | -$0.06 10-K · filed 2019-03-22 | |||
| 2018-03-31 | -$0.11 10-K · filed 2019-03-22 | |||
| 2017-12-31 | -$0.09 10-K · filed 2019-03-22 | -$0.15 derived: net income ÷ weighted average shares · filed 2019-03-22 | -$0.15 derived: net income ÷ weighted average shares · filed 2019-03-22 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-03-22 |
| 2017-09-30 | -$0.06 10-K · filed 2019-03-22 | -$0.06 derived: net income ÷ weighted average shares · filed 2018-11-09 | -$0.05 derived: net income ÷ weighted average shares · filed 2018-11-09 | |
| 2017-06-30 | $0.00 10-K · filed 2019-03-22 | $0.01 derived: net income ÷ weighted average shares · filed 2018-08-13 | ||
| 2017-03-31 | $0.01 10-K · filed 2019-03-22 | |||
| 2016-12-31 | $0.05 10-K · filed 2018-03-20 | |||
| 2016-09-30 | -$0.44 10-K · filed 2018-03-20 | -$2.17 derived: net income ÷ weighted average shares · filed 2017-11-13 | -$1.16 derived: net income ÷ weighted average shares · filed 2017-11-13 | |
| 2016-06-30 | -$5.49 10-K · filed 2018-03-20 | -$716.27 derived: net income ÷ weighted average shares · filed 2017-08-14 | ||
| 2016-03-31 | -$0.02 10-K · filed 2018-03-20 | |||
| 2015-12-31 | -$0.61 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |